Target and Pathway |
Top |
Target(s) |
cAMP protein kinase type II-beta (PRKAR2B) |
Target Info
|
Inhibitor |
[1] |
Epidermal growth factor receptor (EGFR) |
Target Info
|
Inhibitor |
[1] |
Extracellular signal-regulated kinase 2 (ERK2) |
Target Info
|
Inhibitor |
[1] |
FGFR4 messenger RNA (FGFR4 mRNA) |
Target Info
|
Inhibitor |
[1] |
Fibroblast growth factor receptor 1 (FGFR1) |
Target Info
|
Inhibitor |
[1] |
Fibroblast growth factor receptor 2 (FGFR2) |
Target Info
|
Inhibitor |
[1] |
Fibroblast growth factor receptor 3 (FGFR3) |
Target Info
|
Inhibitor |
[1] |
Fungal Protein kinase A (Fung ypkA) |
Target Info
|
Inhibitor |
[1] |
Fyn tyrosine protein kinase (FYN) |
Target Info
|
Inhibitor |
[1] |
Platelet-derived growth factor receptor alpha (PDGFRA) |
Target Info
|
Inhibitor |
[1] |
Platelet-derived growth factor receptor beta (PDGFRB) |
Target Info
|
Inhibitor |
[1] |
PRKACA messenger RNA (PRKACA mRNA) |
Target Info
|
Inhibitor |
[1] |
Vascular endothelial growth factor receptor 2 (KDR) |
Target Info
|
Inhibitor |
[1] |
KEGG Pathway
|
MAPK signaling pathway
|
Ras signaling pathway
|
Rap1 signaling pathway
|
Endocytosis
|
PI3K-Akt signaling pathway
|
Signaling pathways regulating pluripotency of stem cells
|
Regulation of actin cytoskeleton
|
Pathways in cancer
|
MicroRNAs in cancer
|
Bladder cancer
|
Central carbon metabolism in cancer
|
Calcium signaling pathway
|
Cytokine-cytokine receptor interaction
|
Focal adhesion
|
Gap junction
|
HTLV-I infection
|
Glioma
|
Prostate cancer
|
Melanoma
|
Choline metabolism in cancer
|
VEGF signaling pathway
|
Proteoglycans in cancer
|
cAMP signaling pathway
|
Chemokine signaling pathway
|
Oocyte meiosis
|
Apoptosis
|
Adrenergic signaling in cardiomyocytes
|
Vascular smooth muscle contraction
|
Wnt signaling pathway
|
Hedgehog signaling pathway
|
Platelet activation
|
Circadian entrainment
|
Long-term potentiation
|
Retrograde endocannabinoid signaling
|
Glutamatergic synapse
|
Cholinergic synapse
|
Serotonergic synapse
|
GABAergic synapse
|
Dopaminergic synapse
|
Olfactory transduction
|
Taste transduction
|
Inflammatory mediator regulation of TRP channels
|
Insulin signaling pathway
|
Insulin secretion
|
GnRH signaling pathway
|
Ovarian steroidogenesis
|
Progesterone-mediated oocyte maturation
|
Estrogen signaling pathway
|
Melanogenesis
|
Thyroid hormone synthesis
|
Thyroid hormone signaling pathway
|
Oxytocin signaling pathway
|
Glucagon signaling pathway
|
Regulation of lipolysis in adipocytes
|
Renin secretion
|
Endocrine and other factor-regulated calcium reabsorption
|
Vasopressin-regulated water reabsorption
|
Salivary secretion
|
Gastric acid secretion
|
Bile secretion
|
Parkinson's disease
|
Prion diseases
|
Cocaine addiction
|
Amphetamine addiction
|
Morphine addiction
|
Alcoholism
|
Vibrio cholerae infection
|
Amoebiasis
|
Epstein-Barr virus infection
|
Viral carcinogenesis
|
Dilated cardiomyopathy
|
Sphingolipid signaling pathway
|
Axon guidance
|
Osteoclast differentiation
|
Adherens junction
|
Natural killer cell mediated cytotoxicity
|
T cell receptor signaling pathway
|
Fc epsilon RI signaling pathway
|
Pathogenic Escherichia coli infection
|
Measles
|
Viral myocarditis
|
ErbB signaling pathway
|
cGMP-PKG signaling pathway
|
HIF-1 signaling pathway
|
FoxO signaling pathway
|
mTOR signaling pathway
|
Dorso-ventral axis formation
|
TGF-beta signaling pathway
|
Toll-like receptor signaling pathway
|
NOD-like receptor signaling pathway
|
B cell receptor signaling pathway
|
Fc gamma R-mediated phagocytosis
|
TNF signaling pathway
|
Neurotrophin signaling pathway
|
Long-term depression
|
Prolactin signaling pathway
|
Type II diabetes mellitus
|
Aldosterone-regulated sodium reabsorption
|
Alzheimer's disease
|
Shigellosis
|
Salmonella infection
|
Pertussis
|
Leishmaniasis
|
Chagas disease (American trypanosomiasis)
|
Toxoplasmosis
|
Tuberculosis
|
Hepatitis C
|
Hepatitis B
|
Influenza A
|
Colorectal cancer
|
Renal cell carcinoma
|
Pancreatic cancer
|
Endometrial cancer
|
Thyroid cancer
|
Chronic myeloid leukemia
|
Acute myeloid leukemia
|
Non-small cell lung cancer
|
Epithelial cell signaling in Helicobacter pylori infection
|
NetPath Pathway
|
TGF_beta_Receptor Signaling Pathway
|
IL1 Signaling Pathway
|
IL2 Signaling Pathway
|
TSH Signaling Pathway
|
TCR Signaling Pathway
|
IL4 Signaling Pathway
|
EGFR1 Signaling Pathway
|
Panther Pathway
|
FGF signaling pathway
|
Angiogenesis
|
PDGF signaling pathway
|
VEGF signaling pathway
|
Endothelin signaling pathway
|
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
|
Heterotrimeric G-protein signaling pathway-rod outer segment phototransduction
|
Inflammation mediated by chemokine and cytokine signaling pathway
|
Metabotropic glutamate receptor group III pathway
|
Metabotropic glutamate receptor group II pathway
|
Metabotropic glutamate receptor group I pathway
|
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
|
5HT1 type receptor mediated signaling pathway
|
Beta1 adrenergic receptor signaling pathway
|
Beta2 adrenergic receptor signaling pathway
|
Histamine H2 receptor mediated signaling pathway
|
GABA-B receptor II signaling
|
Dopamine receptor mediated signaling pathway
|
Enkephalin release
|
Nicotine pharmacodynamics pathway
|
CCKR signaling map ST
|
Axon guidance mediated by semaphorins
|
Cadherin signaling pathway
|
Integrin signalling pathway
|
Parkinson disease
|
Hedgehog signaling pathway
|
Transcription regulation by bZIP transcription factor
|
Alzheimer disease-amyloid secretase pathway
|
Apoptosis signaling pathway
|
B cell activation
|
EGF receptor signaling pathway
|
Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade
|
Interferon-gamma signaling pathway
|
Interleukin signaling pathway
|
TGF-beta signaling pathway
|
T cell activation
|
Ras Pathway
|
Angiotensin II-stimulated signaling through G proteins and beta-arrestin
|
Pathwhiz Pathway
|
Muscle/Heart Contraction
|
Fc Epsilon Receptor I Signaling in Mast Cells
|
Intracellular Signalling Through Adenosine Receptor A2a and Adenosine
|
Intracellular Signalling Through Adenosine Receptor A2b and Adenosine
|
Insulin Signalling
|
Pathway Interaction Database
|
ATF-2 transcription factor network
|
PDGFR-alpha signaling pathway
|
PDGF receptor signaling network
|
FGF signaling pathway
|
HIF-2-alpha transcription factor network
|
Beta3 integrin cell surface interactions
|
Signaling events mediated by TCPTP
|
SHP2 signaling
|
S1P1 pathway
|
VEGF and VEGFR signaling network
|
Integrins in angiogenesis
|
Signaling events mediated by VEGFR1 and VEGFR2
|
Notch-mediated HES/HEY network
|
GMCSF-mediated signaling events
|
LPA4-mediated signaling events
|
Signaling events regulated by Ret tyrosine kinase
|
LKB1 signaling events
|
Thromboxane A2 receptor signaling
|
Signaling events mediated by HDAC Class I
|
Role of Calcineurin-dependent NFAT signaling in lymphocytes
|
Glucocorticoid receptor regulatory network
|
ErbB2/ErbB3 signaling events
|
IL3-mediated signaling events
|
Syndecan-1-mediated signaling events
|
Retinoic acid receptors-mediated signaling
|
Hedgehog signaling events mediated by Gli proteins
|
VEGFR1 specific signals
|
Calcium signaling in the CD4+ TCR pathway
|
Syndecan-2-mediated signaling events
|
Aurora A signaling
|
Class I PI3K signaling events mediated by Akt
|
Alpha4 beta1 integrin signaling events
|
Fc-epsilon receptor I signaling in mast cells
|
ErbB4 signaling events
|
Glypican 1 network
|
TCR signaling in naï
|
|
Signaling events mediated by PTP1B
|
Ephrin A reverse signaling
|
Reelin signaling pathway
|
Regulation of p38-alpha and p38-beta
|
TCR signaling in naï
|
|
Angiopoietin receptor Tie2-mediated signaling
|
Netrin-mediated signaling events
|
IL2-mediated signaling events
|
CXCR4-mediated signaling events
|
Class I PI3K signaling events
|
Posttranslational regulation of adherens junction stability and dissassembly
|
amb2 Integrin signaling
|
EPHA forward signaling
|
E-cadherin signaling in keratinocytes
|
PDGFR-beta signaling pathway
|
Nephrin/Neph1 signaling in the kidney podocyte
|
Syndecan-3-mediated signaling events
|
Ephrin B reverse signaling
|
Alpha-synuclein signaling
|
Signaling events mediated by focal adhesion kinase
|
S1P3 pathway
|
Nectin adhesion pathway
|
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
|
Validated targets of C-MYC transcriptional repression
|
Syndecan-4-mediated signaling events
|
N-cadherin signaling events
|
Endothelins
|
BCR signaling pathway
|
Signaling events mediated by PRL
|
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)
|
EPHB forward signaling
|
Osteopontin-mediated events
|
S1P4 pathway
|
Presenilin action in Notch and Wnt signaling
|
TRAIL signaling pathway
|
CDC42 signaling events
|
Regulation of Telomerase
|
Arf6 downstream pathway
|
mTOR signaling pathway
|
Class IB PI3K non-lipid kinase events
|
EGF receptor (ErbB1) signaling pathway
|
Ras signaling in the CD4+ TCR pathway
|
Ceramide signaling pathway
|
IFN-gamma pathway
|
ErbB1 downstream signaling
|
BMP receptor signaling
|
ALK1 signaling events
|
Neurotrophic factor-mediated Trk receptor signaling
|
Nongenotropic Androgen signaling
|
CXCR3-mediated signaling events
|
Regulation of cytoplasmic and nuclear SMAD2/3 signaling
|
Cellular roles of Anthrax toxin
|
S1P2 pathway
|
Trk receptor signaling mediated by the MAPK pathway
|
Downstream signaling in naï
|
VEGFR3 signaling in lymphatic endothelium
|
LPA receptor mediated events
|
Arf6 signaling events
|
EGFR-dependent Endothelin signaling events
|
Direct p53 effectors
|
ErbB receptor signaling network
|
Internalization of ErbB1
|
Stabilization and expansion of the E-cadherin adherens junction
|
a6b1 and a6b4 Integrin signaling
|
Reactome
|
FGFR3 mutant receptor activation
|
PIP3 activates AKT signaling
|
Constitutive Signaling by Aberrant PI3K in Cancer
|
RAF/MAP kinase cascade
|
Activated point mutants of FGFR2
|
Neurophilin interactions with VEGF and VEGFR
|
VEGF binds to VEGFR leading to receptor dimerization
|
Integrin cell surface interactions
|
EPHA-mediated growth cone collapse
|
VEGFA-VEGFR2 Pathway
|
VEGFR2 mediated cell proliferation
|
PI3K Cascade
|
FGFR4 ligand binding and activation
|
Phospholipase C-mediated cascade
|
FRS-mediated FGFR4 signaling
|
SHC-mediated cascade:FGFR4
|
PI-3K cascade:FGFR4
|
Negative regulation of FGFR4 signaling
|
Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis
|
PKA activation
|
PKA activation in glucagon signalling
|
DARPP-32 events
|
Regulation of PLK1 Activity at G2/M Transition
|
Loss of Nlp from mitotic centrosomes
|
Recruitment of mitotic centrosome proteins and complexes
|
Loss of proteins required for interphase microtubule organization?from the centrosome
|
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
|
Regulation of insulin secretion
|
Vasopressin regulates renal water homeostasis via Aquaporins
|
Interleukin-3, 5 and GM-CSF signaling
|
Degradation of GLI1 by the proteasome
|
Degradation of GLI2 by the proteasome
|
Hedgehog 'off' state
|
Anchoring of the basal body to the plasma membrane
|
CD209 (DC-SIGN) signaling
|
MAPK6/MAPK4 signaling
|
Gluconeogenesis
|
Factors involved in megakaryocyte development and platelet production
|
GPVI-mediated activation cascade
|
Regulation of KIT signaling
|
Cell surface interactions at the vascular wall
|
FCGR activation
|
PECAM1 interactions
|
DAP12 signaling
|
EPH-Ephrin signaling
|
Role of LAT2/NTAL/LAB on calcium mobilization
|
Nephrin interactions
|
NCAM signaling for neurite out-growth
|
CD28 co-stimulation
|
CD28 dependent PI3K/Akt signaling
|
CD28 dependent Vav1 pathway
|
CTLA4 inhibitory signaling
|
EPHB-mediated forward signaling
|
EPH-ephrin mediated repulsion of cells
|
CRMPs in Sema3A signaling
|
DCC mediated attractive signaling
|
Netrin mediated repulsion signals
|
Dectin-2 family
|
Platelet Adhesion to exposed collagen
|
Regulation of signaling by CBL
|
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
RAF-independent MAPK1/3 activation
|
MAPK1 (ERK2) activation
|
Golgi Cisternae Pericentriolar Stack Reorganization
|
ERK/MAPK targets
|
Regulation of actin dynamics for phagocytic cup formation
|
Oxidative Stress Induced Senescence
|
Senescence-Associated Secretory Phenotype (SASP)
|
Oncogene Induced Senescence
|
FCERI mediated MAPK activation
|
Regulation of HSF1-mediated heat shock response
|
Recycling pathway of L1
|
CREB phosphorylation through the activation of Ras
|
Activation of the AP-1 family of transcription factors
|
Thrombin signalling through proteinase activated receptors (PARs)
|
Negative regulation of FGFR1 signaling
|
Negative regulation of FGFR2 signaling
|
Negative regulation of FGFR3 signaling
|
RHO GTPases Activate WASPs and WAVEs
|
MAP2K and MAPK activation
|
Negative feedback regulation of MAPK pathway
|
Negative regulation of MAPK pathway
|
Signal attenuation
|
Advanced glycosylation endproduct receptor signaling
|
Gastrin-CREB signalling pathway via PKC and MAPK
|
Growth hormone receptor signaling
|
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
|
SHC1 events in ERBB2 signaling
|
PLCG1 events in ERBB2 signaling
|
GRB2 events in EGFR signaling
|
GAB1 signalosome
|
SHC1 events in EGFR signaling
|
EGFR downregulation
|
GRB2 events in ERBB2 signaling
|
PI3K events in ERBB2 signaling
|
EGFR Transactivation by Gastrin
|
Constitutive Signaling by EGFRvIII
|
WikiPathways
|
Regulation of Actin Cytoskeleton
|
Endochondral Ossification
|
Bladder Cancer
|
Neural Crest Differentiation
|
Signaling by FGFR
|
Osteoblast Signaling
|
Focal Adhesion
|
Hair Follicle Development: Organogenesis (Part 2 of 3)
|
PIP3 activates AKT signaling
|
Cardiac Progenitor Differentiation
|
Integrated Pancreatic Cancer Pathway
|
Allograft Rejection
|
Signaling Pathways in Glioblastoma
|
Signaling by PDGF
|
Angiogenesis
|
Ectoderm Differentiation
|
Hair Follicle Development: Induction (Part 1 of 3)
|
Cardiac Hypertrophic Response
|
MicroRNAs in cardiomyocyte hypertrophy
|
Nifedipine Activity
|
Signaling by VEGF
|
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
|
SIDS Susceptibility Pathways
|
Hypothetical Network for Drug Addiction
|
Calcium Regulation in the Cardiac Cell
|
MAPK Signaling Pathway
|
G Protein Signaling Pathways
|
Myometrial Relaxation and Contraction Pathways
|
IL-3 Signaling Pathway
|
Mesodermal Commitment Pathway
|
Human Complement System
|
DAG and IP3 signaling
|
Regulation of Water Balance by Renal Aquaporins
|
Dopamine metabolism
|
Regulation of Microtubule Cytoskeleton
|
FSH signaling pathway
|
miRs in Muscle Cell Differentiation
|
SREBP signalling
|
Opioid Signalling
|
Mitotic G2-G2/M phases
|
Integration of energy metabolism
|
Factors involved in megakaryocyte development and platelet production
|
Nicotine Activity on Dopaminergic Neurons
|
TCR Signaling Pathway
|
Interferon type I signaling pathways
|
IL-2 Signaling Pathway
|
Kit receptor signaling pathway
|
Fc epsilon receptor (FCERI) signaling
|
Signaling by the B Cell Receptor (BCR)
|
Signaling by SCF-KIT
|
DAP12 interactions
|
Host Interactions of HIV factors
|
T-Cell Receptor and Co-stimulatory Signaling
|
Primary Focal Segmental Glomerulosclerosis FSGS
|
BDNF signaling pathway
|
Interleukin-11 Signaling Pathway
|
B Cell Receptor Signaling Pathway
|
Pathogenic Escherichia coli infection
|
TSLP Signaling Pathway
|
IL-7 Signaling Pathway
|
Leptin signaling pathway
|
Semaphorin interactions
|
Platelet Adhesion to exposed collagen
|
Netrin-1 signaling
|
Nephrin interactions
|
NCAM signaling for neurite out-growth
|
Integrin-mediated Cell Adhesion
|
GPVI-mediated activation cascade
|
Costimulation by the CD28 family
|
Cell surface interactions at the vascular wall
|
PDGF Pathway
|
Toll-like receptor signaling pathway
|
Serotonin Receptor 4/6/7 and NR3C Signaling
|
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
|
Serotonin HTR1 Group and FOS Pathway
|
Vitamin A and Carotenoid Metabolism
|
DNA Damage Response (only ATM dependent)
|
ErbB Signaling Pathway
|
Senescence and Autophagy in Cancer
|
EPO Receptor Signaling
|
Insulin Signaling
|
EGF/EGFR Signaling Pathway
|
MAPK Cascade
|
IL-4 Signaling Pathway
|
TGF beta Signaling Pathway
|
IL-6 signaling pathway
|
Signaling of Hepatocyte Growth Factor Receptor
|
TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer
|
Apoptosis-related network due to altered Notch3 in ovarian cancer
|
MAP kinase activation in TLR cascade
|
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
|
RAF/MAP kinase cascade
|
Nanoparticle-mediated activation of receptor signaling
|
Structural Pathway of Interleukin 1 (IL-1)
|
Genes and (Common) Pathways Underlying Drug Addiction
|
EBV LMP1 signaling
|
Signal Transduction of S1P Receptor
|
Aryl Hydrocarbon Receptor
|
Alpha 6 Beta 4 signaling pathway
|
Spinal Cord Injury
|
Oncostatin M Signaling Pathway
|
Corticotropin-releasing hormone
|
AGE/RAGE pathway
|
TNF alpha Signaling Pathway
|
Prostate Cancer
|
IL-9 Signaling Pathway
|
Endothelin Pathways
|
IL17 signaling pathway
|
Alzheimers Disease
|
TWEAK Signaling Pathway
|
RANKL/RANK Signaling Pathway
|
Integrated Breast Cancer Pathway
|
IL-1 signaling pathway
|
Thrombin signalling through proteinase activated receptors (PARs)
|
L1CAM interactions
|
Advanced glycosylation endproduct receptor signaling
|
Heart Development
|
Type II diabetes mellitus
|
Physiological and Pathological Hypertrophy of the Heart
|
Regulation of toll-like receptor signaling pathway
|
Osteopontin Signaling
|
IL-5 Signaling Pathway
|
Aryl Hydrocarbon Receptor Pathway
|
Extracellular vesicle-mediated signaling in recipient cells
|
Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
|
Signaling by ERBB4
|
Signaling by ERBB2
|
Gastrin-CREB signalling pathway via PKC and MAPK
|
Gastric cancer network 2
|
Arylhydrocarbon receptor (AhR) signaling pathway
|
miR-targeted genes in muscle cell - TarBase
|
miR-targeted genes in lymphocytes - TarBase
|
miR-targeted genes in epithelium - TarBase
|
Signaling by EGFR
|